Status:

COMPLETED

Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure

Lead Sponsor:

University of Florida

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this research study is to determine whether atenolol or controlled release carvedilol lower blood pressure in the body as effectively as in the arm. Blood pressure measured in the aorta...

Detailed Description

Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study) is a prospective, open-label, comparative, randomized control tria...

Eligibility Criteria

Inclusion

  • At least 18 years of age
  • Hypertension (untreated or treated with no more then one anti-hypertensive drug)

Exclusion

  • Secondary forms of hypertension (including sleep apnea)
  • Patients currently treated with two or more antihypertensive drugs
  • Patients taking antihypertensive drugs with properly measured clinic systolic blood pressure greater then 170mmHg
  • Isolated systolic hypertension
  • Other diseases requiring treatment with blood pressure lowering medications
  • Heart rate less then 55 beats/min (in the absence of beta-blocker therapy)
  • Known cardiovascular disease including history of angina pectoris, heart failure, presence of a cardiac pacemaker, history of myocardial infarction or revascularization procedure, or cerebrovascular disease (including stroke and TIA)
  • Known diabetes mellitus (Type 1 or 2)
  • Renal insufficiency defined as a serum creatinine greater then 1.5mg/dL in males and 1.4mg/dL in females
  • Primary renal disease
  • Pregnancy or lactation
  • History of Raynaud's syndrome
  • Alcoholism and recreational drug use (due to compliance concerns)

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2010

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT00669279

Start Date

April 1 2008

End Date

July 1 2010

Last Update

October 5 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida

Gainesville, Florida, United States, 32610